Cancer

Ph.D. students Leila Daneshmandi and Armin Tahmasbi Rad, both from the Department of Biomedical Engineering, have developed a technology that takes a patient’s tumor cells and grows them outside of the body to test different cancer treatments. (Evan Olsen Photography)

New Technology Designed to Reduce Mortality Rates in Cancer Patients

A pair of Ph.D. students developed a technology that takes a patient’s tumor cells and grows them outside of the body to test different cancer treatments.

A special team of medical literature experts are on the hunt for cancer's kryptonite, one mutation at a time. (Kailey Whitman Illustration for UConn)

Curators Versus Cancer

A special team of medical literature experts are on the hunt for cancer's kryptonite, one mutation at a time.

Dividing fibrosarcoma cells. Colored scanning electron micrograph of fibrosarcoma (fibroblastic sarcoma) cells in the late telophase stage of mitosis. The cells are covered in many filopodia. Fibrosarcoma is a malignant tumour derived from fibrous connective tissue of the bone and characterized by immature proliferating fibroblasts or undifferentiated anaplastic spindle cells. (Getty Images)

Stopping the Resistance of Cancer Cells to Treatment

UConn researchers have discovered molecules that could make cancer cells more vulnerable to chemotherapy.

Cancer cells tend to hoard iron, and researchers at UConn Health have found that iron may be playing a critical role in fueling the cells' growth through increased fatty acid synthesis. (Yesenia Carrero/UConn Illustration)

Ovarian Cancer Cells Hoard Iron to Fuel Growth

Researchers at UConn Health have found that iron may be playing a critical role in increased fatty acid synthesis in cancer.

An illustration showing interactions between components of the AH10-7 compound (yellow), an immune system antigen presenting cell (gray) and an invariant natural killer T cell (green and blue) that spark activation of iNKT cells in “humanized” mice. (Image courtesy of Jose Gascon/UConn)

New Compound Helps Activate Cancer-Fighting T Cells

UConn researchers have identified mechanisms responsible for improved immune system activity, offering new approaches for more effective cancer treatments and vaccines.

Waking Up. (Image by © Beau Lark/Corbis)

Higher Breast Cancer Risk in Western Parts of Time Zones. Is Electric Light to Blame?

On a societal level, position in a time zone affects how early a person must turn on the lights in the morning.

Woman using her phone under blanket in bed at night. (Getty Images)

Evidence Supports Link Between Breast Cancer, Light Exposure at Night

Artificial light has transformed the night sky, a change researchers continue to link to health problems.

UConn Health's study will be Journal of Neuroscience Research cover story.

A Better View of How Tumors Form in the Eye

UConn Health neuroscientists believe they are closing in on an explanation for the reason our corneas, the transparent layer that forms the front of our eyes, have a natural ability to prevent the formation of tumors.

Female dermatologist examining female patient's skin with dermascope, carefully looking for signs of skin cancer. (Getty Images)

Melanoma’s Signature

On Melanoma Monday, UConn Health dermatologist Sam Dadras discusses his research, which found a molecular signal that could distinguish which skin cancers need more aggressive treatment.

More PSMA, more problems. Prostate cells with more prostate-specific membrane antigen (PSMA) have more cancer cells (purple), growing in a more disorganized way, than the open ducts in a prostate whose cells have little PSMA. (Caromile and Shapiro/UConn Health Image)

Mark of Malignancy Identified in Prostate Cancer

Researchers at UConn Health have identified a protein that appears to indicate how aggressive a prostate cancer will be, potentially leading the way to new treatments.